ISHLT/Enduring Hearts Transplant Longevity Research Award
One of ISHLT’s purposes is to award research grants and establish endowments for the study of heart and lung transplantation and end-stage heart and lung disease. One of the purposes of Enduring Hearts is to promote research to improve longevity of pediatric heart transplants, improve quality of life for transplant recipients, and ultimately reduce and eliminate pediatric heart disease. Our two organizations have joined forces to develop a new award, the , to meet these purposes.
The new , will be bestowed every other year in an amount of up to for the purpose of furthering the scientific understanding surrounding the topic of improving pediatric cardiac graft outcomes and patient quality of life.APPLICATION:
If you have any questions about the application process, please contact Megan Barrett at 972-490-9495 or firstname.lastname@example.org
The purpose of this award is to further the scientific understanding surrounding the topic of improving pediatric cardiac graft outcomes and patient quality of life.
The areas of scientific interest to which the awards will be directed are listed below in order of priority:
- Technology Application: Development of new technologies or applicants thereof that would improve the care of transplant patients and thereby impact outcomes.
- Transplant Immunology: Research and development of novel immunotherapies, identification of novel targets, improving the side effect profiles of these agents as well as better monitoring and measurement of immunosuppression.
- Organ Matching: Strategies and innovations that would allow better organ matching and allocation.
- Nutrition and Exercise Physiology: Strategies and Studies aimed at development of new nutrition and exercise guidelines that improve the long-term outcomes of solid organ transplant recipients.
- Medication Compliance: Strategies to improve medication compliance, especially in adolescent patients and young adults.
- Education: Improving patient and family education related to transplantation.
FUNDING STIPULATIONS / AWARD POLICIES:
- The applicant and the applicant’s chief of staff / research project director must be members of the ISHLT in good standing at the time of application throughout the period of funding.
- The applicant must have completed a clinical or post-doctoral training program. Candidates must have completed their clinical or postdoctoral training no more than 7 years prior to the date of application.
- The research project must be conducted at an accredited university, college, medical or dental school, school of public health, hospital, laboratory, or other non-profit institution.
- No awards will be made for projects that receive overlapping funding from other sources (unless supplementary in nature) or that duplicate other projects already funded.
- The recipient and the recipient’s institution will be required to sign an agreement with ISHLT prior to receiving any portion of the funding.
- Research must begin between May 1 and December 31 of the award year.
- The funds must be used within 1 year of the final installment disbursement date, unless and extension is approved by the ISHLT Grants & Awards Committee and the Enduring Hearts Scientific Advisory Committee.
- The results of funded research must be submitted in one of the following formats within two years of the initial date of funding:
• As a manuscript to the Journal of Heart and Lung Transplantation
• As an abstract for the ISHLT Annual Meeting and Scientific Sessions
• As a report for publication in the Journal of Heart and Lung Transplantation
- The results of the funded research cannot have been previously published or presented prior to publication in the Journal of Heart and Lung Transplantation or presentation at the ISHLT Annual Meeting.
- ISHLT and Enduring Hearts must be acknowledged as a funding source in all manuscripts and presentations derived from the funded research via the following statement, “This work was supported by a research award from Enduring Hearts and the International Society for Heart and Lung Transplantation”. Copies of these presentations / publications must be submitted to the ISHLT Headquarters office and the Enduring Hearts Headquarters office within 1 month of presentation / publication.
- Funding will be awarded to the institution in two portions. 50% of the funding will be provided initially, with the remaining 50% provided upon submission of a progress report to the ISHLT Grants & Awards Committee 12 months after the date of initial funding. The second installment of funding will not be made if the research is no longer being conducted at the original institution.
- The award recipient’s institution agrees that the funds will be expended for the purpose(s) described in the application, that there is no duplicate funding for these purposes, and that no portion of the award will be used to pay for indirect costs, or institutional overhead. If the overall project budget includes the purchase of capital equipment, these expenditures must be reviewed and approved by the Enduring Hearts Scientific Advisory Committee and the Enduring Hearts Finance Committee.
- The award recipient or his/her research project director must be present at the Awards Session at the ISHLT Annual Meeting to receive acknowledgement of the award.